{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:57:06Z","timestamp":1781729826024,"version":"3.54.5"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5U19AI062629"],"award-info":[{"award-number":["5U19AI062629"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["3T32AI007633"],"award-info":[{"award-number":["3T32AI007633"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["3P30GM103510"],"award-info":[{"award-number":["3P30GM103510"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["5U54GM104938"],"award-info":[{"award-number":["5U54GM104938"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Oklahoma Medical Research Foundation J. Donald and Patricia Capra Fellowship"},{"name":"Oklahoma Medical Research Foundation Lou C. Kerr Chair in Biomedical Research"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0230782","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T17:30:17Z","timestamp":1586971817000},"page":"e0230782","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes"],"prefix":"10.1371","volume":"15","author":[{"given":"Eric K.","family":"Dumas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayati","family":"Demiraslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Muns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Larabee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Garman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy D.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert-Jan","family":"Boons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5323-0796","authenticated-orcid":true,"given":"Uner","family":"Kayabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3922-4901","authenticated-orcid":true,"given":"Mehmet","family":"Doganay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3009-2017","authenticated-orcid":true,"given":"A. Darise","family":"Farris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"issue":"6","key":"pone.0230782.ref001","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"JA Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"22","key":"pone.0230782.ref002","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMra012892","article-title":"Recognition and management of anthrax\u2014an update","volume":"345","author":"MN Swartz","year":"2001","journal-title":"N Engl J Med"},{"issue":"32","key":"pone.0230782.ref003","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.32.20877","article-title":"Injectional anthrax\u2014new presentation of an old disease","volume":"19","author":"T Berger","year":"2014","journal-title":"Euro Surveill"},{"key":"pone.0230782.ref004","volume-title":"WHO Guidelines Approved by the Guidelines Review Committee","author":"Anthrax in Humans and Animals","year":"2008"},{"issue":"3","key":"pone.0230782.ref005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jiph.2010.07.004","article-title":"A review of cutaneous anthrax and its outcome","volume":"3","author":"M Doganay","year":"2010","journal-title":"J Infect Public Health"},{"issue":"11","key":"pone.0230782.ref006","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"TC Dixon","year":"1999","journal-title":"N Engl J Med"},{"key":"pone.0230782.ref007","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"M Mock","year":"2001","journal-title":"Annu Rev Microbiol"},{"issue":"3","key":"pone.0230782.ref008","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/bj0630437","article-title":"Polyglutamic acid from Bacillus anthracis grown in vivo; structure and aggressin activity","volume":"63","author":"HT Zwartouw","year":"1956","journal-title":"Biochem J"},{"key":"pone.0230782.ref009","first-page":"49","article-title":"Purification of factor I and recognition of a third factor of the anthrax toxin","volume":"26","author":"JL Stanley","year":"1961","journal-title":"J Gen Microbiol"},{"key":"pone.0230782.ref010","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1099\/00221287-22-1-206","article-title":"Purification of factors I and II of the anthrax toxin produced in vivo","volume":"22","author":"JL Stanley","year":"1960","journal-title":"J Gen Microbiol"},{"issue":"6860","key":"pone.0230782.ref011","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"KA Bradley","year":"2001","journal-title":"Nature"},{"issue":"6","key":"pone.0230782.ref012","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2958.1994.tb00500.x","article-title":"Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity","volume":"13","author":"KR Klimpel","year":"1994","journal-title":"Mol Microbiol"},{"issue":"10","key":"pone.0230782.ref013","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"SH Leppla","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pone.0230782.ref014","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.mam.2009.06.002","article-title":"Anthrax toxins: a weapon to systematically dismantle the host immune defenses","volume":"30","author":"JN Tournier","year":"2009","journal-title":"Mol Aspects Med"},{"key":"pone.0230782.ref015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-micro-091014-104523","article-title":"Anthrax Pathogenesis","volume":"69","author":"M Moayeri","year":"2015","journal-title":"Annu Rev Microbiol"},{"issue":"2","key":"pone.0230782.ref016","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1574-695X.2011.00800.x","article-title":"The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax","volume":"62","author":"KE Brenneman","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"7","key":"pone.0230782.ref017","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.4049\/jimmunol.0901581","article-title":"Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes","volume":"184","author":"RJ Ingram","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"pone.0230782.ref018","doi-asserted-by":"crossref","first-page":"e0148713","DOI":"10.1371\/journal.pone.0148713","article-title":"A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines","volume":"11","author":"TR Laws","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"pone.0230782.ref019","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/infdis\/jir543","article-title":"Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax","volume":"204","author":"AE Boyer","year":"2011","journal-title":"J Infect Dis"},{"issue":"2","key":"pone.0230782.ref020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/653495","article-title":"Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge","volume":"202","author":"SR Crowe","year":"2010","journal-title":"J Infect Dis"},{"issue":"20","key":"pone.0230782.ref021","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.vaccine.2011.03.011","article-title":"Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity","volume":"29","author":"SR Crowe","year":"2011","journal-title":"Vaccine"},{"issue":"28","key":"pone.0230782.ref022","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1016\/j.vaccine.2012.03.002","article-title":"Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization","volume":"30","author":"K Smith","year":"2012","journal-title":"Vaccine"},{"key":"pone.0230782.ref023","article-title":"Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-specific antibodies in human recipients","author":"EK Duman","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"pone.0230782.ref024","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3201\/eid0810.020380","article-title":"Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen","volume":"8","author":"CP Quinn","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"pone.0230782.ref025","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1128\/IAI.00884-07","article-title":"Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen","volume":"75","author":"TN Brahmbhatt","year":"2007","journal-title":"Infection and immunity"},{"issue":"36","key":"pone.0230782.ref026","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1002\/chem.200601245","article-title":"Synthesis and antigenic analysis of the BclA glycoprotein oligosaccharide from the Bacillus anthracis exosporium","volume":"12","author":"AS Mehta","year":"2006","journal-title":"Chemistry"},{"issue":"5","key":"pone.0230782.ref027","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/CVI.00475-10","article-title":"Antibody responses to a spore carbohydrate antigen as a marker of nonfatal inhalation anthrax in rhesus macaques","volume":"18","author":"E Saile","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"pone.0230782.ref028","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1365-2672.2007.03391.x","article-title":"A study of the physiology of Bacillus anthracis Sterne during manufacture of the UK acellular anthrax vaccine","volume":"103","author":"S Charlton","year":"2007","journal-title":"J Appl Microbiol"},{"issue":"1\u20132","key":"pone.0230782.ref029","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2008.01.007","article-title":"Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization","volume":"333","author":"H Li","year":"2008","journal-title":"J Immunol Methods"},{"issue":"8","key":"pone.0230782.ref030","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1128\/IAI.05070-11","article-title":"Glycogen synthase kinase 3 activation is important for anthrax edema toxin-induced dendritic cell maturation and anthrax toxin receptor 2 expression in macrophages","volume":"79","author":"JL Larabee","year":"2011","journal-title":"Infect Immun"},{"issue":"6","key":"pone.0230782.ref031","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-3083.1994.tb03413.x","article-title":"Basic amino acids predominate in the sequential autoantigenic determinants of the small nuclear 70K ribonucleoprotein","volume":"39","author":"JA James","year":"1994","journal-title":"Scand J Immunol"},{"key":"pone.0230782.ref032","first-page":"32","article-title":"Serologic testing for anthrax antibodies in workers in a goat hair processing mill","volume":"72","author":"PS Norman","year":"1960","journal-title":"Am J Hyg"},{"issue":"10","key":"pone.0230782.ref033","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3201\/eid1510.081717","article-title":"Immunologic response of unvaccinated workers exposed to anthrax, Belgium","volume":"15","author":"P Wattiau","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"pone.0230782.ref034","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1017\/S0950268811001488","article-title":"B. anthracis in a wool-processing factory: seroprevalence and occupational risk","volume":"140","author":"E Kissling","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"2","key":"pone.0230782.ref035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/510312","article-title":"The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics","volume":"195","author":"DL Doolan","year":"2007","journal-title":"J Infect Dis"},{"issue":"26","key":"pone.0230782.ref036","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1016\/j.vaccine.2017.05.006","article-title":"Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated","volume":"35","author":"EK Dumas","year":"2017","journal-title":"Vaccine"},{"issue":"11","key":"pone.0230782.ref037","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00165-17","article-title":"Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients","volume":"24","author":"EK Dumas","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"pone.0230782.ref038","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0264-410X(91)90237-Z","article-title":"Anthrax vaccines: past, present and future","volume":"9","author":"PC Turnbull","year":"1991","journal-title":"Vaccine"},{"issue":"RR-6","key":"pone.0230782.ref039","first-page":"1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009","volume":"59","author":"JG Wright","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"pone.0230782.ref040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cei.12090","article-title":"Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1","volume":"173","author":"RJ Ingram","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"pone.0230782.ref041","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13578-015-0011-4","article-title":"Natural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokines","volume":"5","author":"RJ Ingram","year":"2015","journal-title":"Cell Biosci"},{"issue":"5","key":"pone.0230782.ref042","doi-asserted-by":"crossref","first-page":"e1004085","DOI":"10.1371\/journal.ppat.1004085","article-title":"Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity","volume":"10","author":"S Ascough","year":"2014","journal-title":"PLoS Pathog"},{"issue":"2","key":"pone.0230782.ref043","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/IAI.52.2.356-363.1986","article-title":"Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"52","author":"PC Turnbull","year":"1986","journal-title":"Infection and immunity"},{"issue":"5","key":"pone.0230782.ref044","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00189414","article-title":"Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"177","author":"PC Turnbull","year":"1988","journal-title":"Med Microbiol Immunol (Berl)"},{"issue":"10","key":"pone.0230782.ref045","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.vaccine.2006.11.028","article-title":"Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax","volume":"25","author":"VA Semenova","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"pone.0230782.ref046","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4269\/ajtmh.1988.39.575","article-title":"Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand","volume":"39","author":"T Sirisanthana","year":"1988","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"pone.0230782.ref047","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/infdis\/160.4.706","article-title":"Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay","volume":"160","author":"LH Harrison","year":"1989","journal-title":"J Infect Dis"},{"issue":"9","key":"pone.0230782.ref048","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/BF01960887","article-title":"Familial outbreak of agricultural anthrax in an area of northern Italy","volume":"11","author":"F de Lalla","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"pone.0230782.ref049","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1086\/423937","article-title":"Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax","volume":"190","author":"CP Quinn","year":"2004","journal-title":"J Infect Dis"},{"issue":"8","key":"pone.0230782.ref050","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1128\/CVI.00154-12","article-title":"Anti-protective antigen IgG enzyme-linked immunosorbent assay for diagnosis of cutaneous anthrax in India","volume":"19","author":"N Ghosh","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"pone.0230782.ref051","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1128\/CVI.00598-12","article-title":"Serodiagnosis of human cutaneous anthrax in India using an indirect anti-lethal factor IgG enzyme-linked immunosorbent assay","volume":"20","author":"N Ghosh","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"pone.0230782.ref052","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1074\/jbc.M509432200","article-title":"Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy","volume":"281","author":"J Joyce","year":"2006","journal-title":"The Journal of biological chemistry"},{"issue":"34","key":"pone.0230782.ref053","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1016\/j.vaccine.2016.06.031","article-title":"Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine","volume":"34","author":"DJ Chabot","year":"2016","journal-title":"Vaccine"},{"issue":"Pt 10","key":"pone.0230782.ref054","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1099\/jmm.0.045393-0","article-title":"Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia","volume":"61","author":"CK Cote","year":"2012","journal-title":"J Med Microbiol"},{"issue":"24","key":"pone.0230782.ref055","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1016\/j.vaccine.2015.04.049","article-title":"BclA and toxin antigens augment each other to protect NMRI mice from lethal Bacillus anthracis challenge","volume":"33","author":"SM Kohler","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"pone.0230782.ref056","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1365-2672.2008.04129.x","article-title":"Immuno-detection of anthrose containing tetrasaccharide in the exosporium of Bacillus anthracis and Bacillus cereus strains","volume":"106","author":"M Tamborrini","year":"2009","journal-title":"J Appl Microbiol"},{"issue":"24","key":"pone.0230782.ref057","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1039\/b914534f","article-title":"Sensitive and specific enzyme immunoassays for antigenic trisaccharide from Bacillus anthracis spores","volume":"7","author":"SG Dhenin","year":"2009","journal-title":"Org Biomol Chem"},{"issue":"11","key":"pone.0230782.ref058","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1128\/CVI.00469-14","article-title":"Comprehensive analysis and selection of anthrax vaccine adsorbed immune correlates of protection in rhesus macaques","volume":"21","author":"L Chen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"pone.0230782.ref059","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1128\/CVI.00174-10","article-title":"Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro","volume":"17","author":"KH Clement","year":"2010","journal-title":"Clin Vaccine Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T17:30:55Z","timestamp":1586971855000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230782"}},"subtitle":[],"editor":[{"given":"Wendy C.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":59,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0230782","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]}}}